Wed, March 24, 2021
Tue, March 23, 2021
Mon, March 22, 2021

Tiago Fauth Maintained (SPRB) at Buy with Decreased Target to $26 on, Mar 23rd, 2021

Tiago Fauth of Credit Suisse, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy with Decreased Target from $28 to $26 on, Mar 23rd, 2021.

Tiago, nor any peers, have made any analyst calls on SPRB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30